CellRapeutics™ Leukopak from Lymphoma Donor (XS-0426-XU251)

Name: CellRapeutics™ Leukopak from Lymphoma Donor
SKU: XS-0426-XU251
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product features a concentrated leucocyte collection from donors diagnosed with B-cell or T-cell Lymphoma. The specimen provides an extensive source of primary cells that reflect the systemic burden of hematological malignancy, often containing circulating malignant clones alongside a dysregulated reactive immune environment. It serves as an essential resource for developing chimeric antigen receptor therapies, studying clonal evolution, and identifying novel cell-surface markers for lymphoma stratification.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Lymphoma Donor

Cat. No.
XS-0426-XU251

Donor Age
Middle-Aged, Senior

Donor Health
Donors are diagnosed with lymphoid malignancy. The leukocyte profile is marked by expanded malignant clones or their systemic effects on the normal immune repertoire, including altered lymphocyte subset distributions.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, prioritized to maximize the collection efficiency of malignant vs. healthy B-cell subsets and maintain viability.

Additional Donor Information
Each lot features a Leukopak from donors with diagnosed Hodgkin's or Non-Hodgkin's Lymphoma. Profiles include subtype identification and chemotherapy history, essential for studying malignant lymphocyte behavior and CAR-T development.

Clinical Profile
Histological subtype, stage at collection, treatment history, and current remission status.

Additional Information

Medication History
Available upon request. Includes history of multi-agent chemotherapy, anti-CD20 monoclonal antibodies, and documentation of remission or refractory status.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Lymphoma Donor, Leukopak, Lymphoma

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Lymphoma Donor (XS-0426-XU251). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.